November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 9, 2011 — Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
November 09, 2011
October 24, 2011 — A new study demonstrates that angiotensin-converting enzyme (ACE) inhibitors taken in the first ...
October 24, 2011
October 24, 2011 – The American College of Cardiology (ACC) announced it is expanding its outpatient PINNACLE Registry ...
October 24, 2011October 4, 2011 – Roche announced plans today to expand its coagulation testing product line in North America beyond ...
October 04, 2011
September 28, 2011 — A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in ...
September 28, 2011September 15, 2011 – The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first ...
September 16, 2011
September 8, 2011 – A randomized multicenter, open-label study evaluating the efficacy and safety of prolonged ...
September 08, 2011September 8, 2011 – Patients at a high risk for a second stroke who received intensive medical treatment had fewer ...
September 08, 2011
September 6, 2011 — The European Society of Cardiology (ESC) released the latest version of its guidelines for managing ...
September 06, 2011August 30, 2011 – Compared with patients who had persistently high platelet reactivity, those who achieved low platelet ...
August 30, 2011
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...
August 19, 2011Aug. 2, 2011 — New York University (NYU) Langone Medical Center received an $84 million grant from the National Heart ...
August 02, 2011
July 21, 2011 – The U.S. Food and Drug Administration (FDA) today approved AstraZeneca’s blood-thinning drug ticagrelor ...
July 21, 2011
July 5, 2011 — Janssen Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...
July 05, 2011